RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
  Bone Cancer
  Breast Cancer
  Cervical Cancer
  Gastric Cancer
  Liver Cancer
  Nerve Tissue
  Ovarian Cancer
  Pancreatic Cancer
  Prostate Cancer
  Rectal Cancer
  Renal Cell Carcinoma
  Risk Factors
  Testicular Cancer
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Ovarian Cancer Channel

subscribe to Ovarian Cancer newsletter
Latest Research : Cancer : Ovarian Cancer

   EMAIL   |   PRINT
Ovarian cancer vaccine trials show promise

Oct 13, 2007 - 2:23:02 PM
Most patients with advanced disease respond to drug treatments but more than 70 percent die from a recurrence of the cancer within five years of diagnosis.

[RxPG] New York, Oct 13 - Scientists in the US have developed a vaccine to fight ovarian cancer, and it has shown encouraging results in preliminary trials.

The vaccine developed by scientists led by Kunle Odunsi at the Roswell Park Cancer Institute in Buffalo enhances the body's own immune response to the cancer, reported the online edition of BBC News.

The researchers tested the vaccine in women with epithelial ovarian cancer, a type of cancer that originates on the covering of the ovaries.

'There is now compelling evidence that the immune system has the capacity to recognise and kill ovarian cancer cells. We are confident that the vaccine will eventually be widely available,' Odunsi said.

Ovarian cancer is the development of a tumour on or within an ovary. It usually happens in women who are over 50 years of age but it can also affect younger women. Its cause is unknown. Treatment is usually surgery followed by treatment with medicines.

Most patients with advanced disease respond to drug treatments but more than 70 percent die from a recurrence of the cancer within five years of diagnosis.

It is the fourth most common type of cancer in women and fifth leading cause of cancer death in the US. In India, according to the Indian Council of Medical Research, the crude incidence rate of this cancer is 4.2 per 100,000 women.

Advertise in this space for $10 per month. Contact us today.

Related Ovarian Cancer News
New technique to visualise tumour cells during surgery
Autophagy helps ovarian cancer cells to survive
Ovarian cancer vaccine trials show promise
VEGF Trap shows activity in patients with advanced ovarian cancer
UBC discovery may lead to focussed therapies for metastatic breast, ovarian cancer
Ovariectomy may put younger women at risk for an earlier death
Chronic stress agitates ovarian cancer
Acetaminophen may lower ovarian cancer risk
Ginger could help fight ovarian cancer
Multimarker assay for ovarian cancer most promising to date

Subscribe to Ovarian Cancer Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)